Dexcom Launches Inaugural Venture Capital Fund
February 11 2021 - 4:10PM
Business Wire
Dexcom Ventures to identify and invest in
transformational technologies to advance long-term growth
DexCom, Inc. (Nasdaq: DXCM), the global leader in continuous
glucose monitoring for people with diabetes, today announced the
launch of Dexcom Ventures. The inaugural fund will seek to identify
and invest in opportunities to supplement growth in the core
business and advance the development of adjacent technologies for
the future.
Dexcom Ventures will be led by Dexcom veteran Steve Pacelli and
will be focused on investment opportunities in sensing technology,
data analytics, remote patient monitoring and population health,
broadening Dexcom’s commitment to advancing better outcomes in
healthcare.
“Driven by core technologies that our teams have developed
internally, Dexcom continues to achieve strong growth and expand
our future markets,” said Kevin Sayer, chairman, president and CEO
of Dexcom. “By establishing Dexcom Ventures, we believe we can
advance innovative technologies that enable better health outcomes
and complement our growth opportunity. I have full confidence in
Steve and his team as they lead this exciting new effort.”
The fund will support independent initiatives in glucose sensing
technologies and in adjacent fields of metabolic monitoring and
marks the entrance into the venture capital space for parent
company Dexcom.
“We strive to be value-add strategic investors by leveraging
access to Dexcom’s unique industry expertise and technology
leadership,” Pacelli said. “While we have matured as a company over
the years, we still consider ourselves to be a ‘start-up’ of sorts.
We feel well positioned to invest early and support our portfolio
companies as they pioneer markets.’’
About Dexcom
DexCom, Inc. empowers people to take control of diabetes through
innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, California, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
users, caregivers, and providers, Dexcom simplifies and improves
diabetes management around the world.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210211005871/en/
INVESTOR RELATIONS CONTACT: Sean Christensen Director of
Corporate Affairs and Head of Investor Relations
investor-relations@dexcom.com (858) 200-0200
MEDIA CONTACT: James McIntosh (619) 884-2118
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Mar 2024 to Apr 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2023 to Apr 2024